SHL Telemedicine Ltd. announced that its Board has resolved to appoint Mr. Yoav Rubinstein as an interim acting CEO. Mr. Rubinstein has been serving as the company's senior vice president and Head of Global Business since 2012. The company has further appointed Mr. Yossi Vadnagra as its interim acting CFO. Mr. Vadnagra has been serving as the company's Director of Business Development for Israel in recent months and has previously worked with SHL in India.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.36 CHF | -4.80% |
|
-6.24% | -37.27% |
06-20 | SHL Telemedicine Confirms Talks With Israeli Firm About Potential Investment | MT |
05-21 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Fresh Catalysts | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.27% | 83.42M | |
+133.48% | 4.4B | |
-16.14% | 365M | |
+8.04% | 353M | |
-79.09% | 89.74M |
- Stock Market
- Equities
- SHLTN Stock
- News SHL Telemedicine Ltd.
- SHL Telemedicine Ltd. Announces Executive Changes